MEDI-528, now recognized as enokizumumab, represents a groundbreaking therapeutic targeting the IGF1R, a crucial protein involved in multiple dermatological diseases . Early clinical data suggest https://mayanpwu865832.wikiexpression.com/6508250/enokizumab_a_deep_dive_into_medi_528_and_its_potential